The US Food and Drug Administration announced that it has approved Eli Lilly's tadalafil tablets to be used in treating erectile dysfunction and benign prostatic hyperplasia or BPH, a condition in which the prostate gland is enlarged and may lead to urinary symptoms.
The tablets, which will be sold under the brandname Cialis, will now be used for treating erectile dysfunction and signs and symptoms of BPH separately. Additionally, it will also be used to treat patients who have ED along with the signs and symptoms of BPH.
AdvertisementThe approval comes following clinical trials which showed that the drug was better than placebo in treating patients with ED and ED plus BPH.
P Food Ads on TV Dictate Meal Choices Among Kids Pediatric Research: Does MRI Pose More Than Minimal Risk? M
You May Also Like